Lawrence Deyton

4.5k total citations · 1 hit paper
36 papers, 3.5k citations indexed

About

Lawrence Deyton is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Lawrence Deyton has authored 36 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 10 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Lawrence Deyton's work include HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (12 papers) and HIV Research and Treatment (10 papers). Lawrence Deyton is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (12 papers) and HIV Research and Treatment (10 papers). Lawrence Deyton collaborates with scholars based in United States, United Kingdom and India. Lawrence Deyton's co-authors include Judith Feinberg, Jon C. Cook, Scott M. Hammer, Jeffrey Chodakewitz, John Phair, Lisa M. Demeter, Kathleen Squires, Michael D. Hughes, Joseph J. Eron and Henry H. Balfour and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Lawrence Deyton

32 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

1997 2.1k citations Judith Feinberg, Lawrence Deyton et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence Deyton United States	18	2.2k	1.9k	762	453	305	36	3.5k
Katherine Huppler Hullsiek United States	31	1.6k 0.8×	1.2k 0.7×	1.1k 1.5×	672 1.5×	312 1.0×	52	2.9k
Maureen Myers United States	24	2.4k 1.1×	1.7k 0.9×	1.4k 1.9×	306 0.7×	253 0.8×	36	3.8k
William Spreen United States	30	2.4k 1.1×	1.8k 1.0×	693 0.9×	344 0.8×	100 0.3×	80	3.6k
Camlin Tierney United States	21	1.7k 0.8×	1.2k 0.6×	383 0.5×	899 2.0×	174 0.6×	60	2.4k
Heather J. Ribaudo United States	34	3.2k 1.5×	2.4k 1.3×	658 0.9×	1.6k 3.5×	194 0.6×	112	4.4k
Matthew Koch United States	29	1.0k 0.5×	740 0.4×	542 0.7×	195 0.4×	158 0.5×	53	3.4k
Dannie H. King United States	6	1.7k 0.8×	1.3k 0.7×	997 1.3×	213 0.5×	199 0.7×	8	2.7k
Bach‐Yen Nguyen United States	20	3.4k 1.6×	2.9k 1.5×	1.0k 1.3×	600 1.3×	111 0.4×	25	4.2k
Mark S. Shaefer United States	24	1.5k 0.7×	1.1k 0.6×	419 0.5×	438 1.0×	91 0.3×	79	2.4k
Calvin Cohen United States	32	4.7k 2.2×	3.8k 2.0×	874 1.1×	1.0k 2.2×	127 0.4×	80	5.5k

Countries citing papers authored by Lawrence Deyton

Since Specialization

Citations

This map shows the geographic impact of Lawrence Deyton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Deyton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Deyton more than expected).

Fields of papers citing papers by Lawrence Deyton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Deyton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Deyton. The network helps show where Lawrence Deyton may publish in the future.

Co-authorship network of co-authors of Lawrence Deyton

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Deyton. A scholar is included among the top collaborators of Lawrence Deyton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Deyton. Lawrence Deyton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cotter, Elizabeth W., et al.. (2025). Reckoning with the past: a qualitative analysis of medical students describing their formative experiences with weight bias. Journal of Eating Disorders. 13(1). 50–50.

Maeshiro, Rika, Jacob Prunuske, Jan K. Carney, et al.. (2023). Public and Population Health in U.S. Medical Education: A Review of Guidance in Extraordinary Times. Academic Medicine. 98(12). 1366–1380.

Dooley, Danielle G., et al.. (2020). Teaching Trauma-Informed Care: A Symposium for Medical Students. MedEdPORTAL. 16. 11061–11061. 23 indexed citations

Fair, Malika, Lisa D. Howley, Jacob Prunuske, et al.. (2020). Teaching Public and Population Health in Medical Education: An Evaluation Framework. Academic Medicine. 95(12). 1853–1863. 15 indexed citations

Deyton, Lawrence. (2012). Center for Tobacco Products. 2 indexed citations

Deyton, Lawrence, Joshua Sharfstein, & Margaret Hamburg. (2010). Tobacco Product Regulation — A Public Health Approach. New England Journal of Medicine. 362(19). 1753–1756. 59 indexed citations

Lurie, Nicole, et al.. (2008). Community Planning for Pandemic Influenza: Lessons From the VA Health Care System. Disaster Medicine and Public Health Preparedness. 2(4). 251–257. 19 indexed citations

Holodniy, Mark, Scott Penzak, Timothy M. Straight, et al.. (2008). Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid. Antimicrobial Agents and Chemotherapy. 52(9). 3013–3021. 44 indexed citations

Deyton, Lawrence, et al.. (2008). War, Its Aftermath, and U.S. Health Policy: Toward a Comprehensive Health Program for America's Military Personnel, Veterans, and Their Families. The Journal of Law Medicine & Ethics. 36(4). 677–689. 9 indexed citations

10.

Holodniy, Mark, et al.. (2006). Relationship Between Antiretroviral Prescribing Patterns and Treatment Guidelines in Treatment-Naive HIV-1-Infected US Veterans (1992-2004). JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(1). 20–29. 23 indexed citations

11.

Backus, Lisa I., L Molé, Sophia W. Chang, & Lawrence Deyton. (2001). The immunology case registry. Journal of Clinical Epidemiology. 54(12). S12–S15. 47 indexed citations

12.

Bozzette, Samuel A., Barbara Phillips, Steven M. Asch, et al.. (2000). Quality Enhancement Research Initiative for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Medical Care. 38(6). I–60. 2 indexed citations

13.

Rhame, Frank S., Richard W. Price, David C. Perlman, et al.. (1998). Experience with a cross-study endpoint review committee for AIDS clinical trials. AIDS. 12(15). 1983–1990. 16 indexed citations

14.

Neaton, James D., et al.. (1996). CD4+ T Lymphocyte Counts and Patterns of Mortality Among Patients Infected with Human Immunodeficiency Virus Who Were Enrolled in Community Programs for Clinical Research on AIDS. Clinical Infectious Diseases. 22(3). 513–520. 14 indexed citations

15.

Goldman, Anne I., Bradley P. Carlin, Lawrence R. Crane, et al.. (1996). Response of CD4 Lymphocytes and Clinical Consequences of Treatment Using ddI or ddC In Patients with Advanced HIV Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 11(2). 161–169. 43 indexed citations

16.

Abrams, Donald I., Anne I. Goldman, Cynthia A. Launer, et al.. (1994). A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 330(10). 657–662. 150 indexed citations

17.

Jacobson, Mark Z., C. Lynn Besch, Carroll Child, et al.. (1994). Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial. The Journal of Infectious Diseases. 169(2). 384–394. 40 indexed citations

18.

Davey, Richard T., Lawrence Deyton, Joseph A. Kovacs, et al.. (1992). Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure. Journal of Clinical Immunology. 12(3). 185–192. 9 indexed citations

19.

Deyton, Lawrence, Robert Walker, Joseph A. Kovacs, et al.. (1989). Reversible Cardiac Dysfunction Associated with Interferon Alfa Therapy in AIDS Patients with Kaposi's Sarcoma. New England Journal of Medicine. 321(18). 1246–1249. 97 indexed citations

20.

Lane, H. Clifford, Judith Feinberg, Victoria J. Davey, et al.. (1988). ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA. The Lancet. 332(8622). 1218–1222. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact